Madrigal Pharmaceuticals Prices $500M Public Offering At $151.69/Share For 1,248,098 Common Shares And $151.6899/Pre-Funded Warrant For 2,048,098 Warrants
Portfolio Pulse from Benzinga Newsdesk
Madrigal Pharmaceuticals has priced its public offering at $151.69 per share for 1,248,098 common shares and $151.6899 per pre-funded warrant for 2,048,098 warrants, raising a total of $500 million.
September 29, 2023 | 7:20 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Madrigal Pharmaceuticals' public offering could dilute existing shareholders' equity, potentially leading to a short-term decrease in stock price.
Public offerings often lead to dilution of existing shareholders' equity, which can result in a short-term decrease in stock price. Given the size of the offering, the impact on Madrigal's stock price could be significant.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100